TSXV: ACB
VANCOUVER, July 10, 2017 /CNW/ - Aurora Cannabis Inc. (the
"Company" or "Aurora") (TSXV: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today
that the Company has received conditional approval from the Toronto
Stock Exchange (the "TSX") to graduate from the TSX Venture
Exchange and list its common shares on the TSX. Upon receiving
final approval, the common shares will continue to trade under the
symbol "ACB". In conjunction with listing on the TSX, the common
shares will be voluntarily delisted from the TSX Venture Exchange
prior to the commencement of trading on the TSX.
"Aurora's graduation to the TSX, for which we anticipate
receiving final approval imminently, is another exciting milestone,
reflecting our remarkable pace of growth and expansion, both across
Canada and internationally," said
Terry Booth, CEO. "Since we began
commercial operations 18 months ago, Aurora has established itself
as a driving force, with one of the strongest brands in the
cannabis industry, due to constant innovation and consistent
execution. Tangible developments, such as the construction of
Aurora Sky, our 100,000 kg per year cannabis production facility,
the acquisitions in Québec and Germany, as well as our strategic investments
in Cann Group in Australia, and
Radient Technologies in Alberta,
reflect how Aurora continues to set new standards in the industry.
Having uplisted from the CSE to the TSXV in October, 2016, we
believe that now graduating to the TSX will enable us to address an
even wider investor audience, both domestically and
internationally. We remain focused strongly on building shareholder
value, and look forward to reporting on our progress as a member of
Canada's flagship stock
exchange."
About Aurora
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises
Inc., is a licensed producer of medical cannabis pursuant to Health
Canada's Access to Cannabis for Medical Purposes Regulations
("ACMPR"). The Company operates a 55,200 square foot,
state-of-the-art production facility in Mountain View County,
Alberta, and is currently
constructing a second 800,000 square foot production facility,
known as "Aurora Sky", at the Edmonton International Airport, and has
acquired, and is undertaking completion of, a third 40,000 square
foot production facility in Pointe-Claire, Quebec, on Montreal's West Island. In
addition, the company is the cornerstone investor with a 19.9%
stake in Cann Group Limited, the first Australian company licensed
to conduct research on and cultivate medical cannabis, as well as
owns Pedanios, a leading wholesale importer, exporter, and
distributor of medical cannabis in the European Union ("EU"), based
in Germany. Aurora's common shares trade on the TSX-V under
the symbol "ACB".
On behalf of the Board of Directors,
AURORA CANNABIS INC.
Terry Booth, CEO
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. These statements are only predictions.
Various assumptions were used in drawing the conclusions or making
the projections contained in the forward-looking statements
throughout this news release. Forward-looking statements are based
on the opinions and estimates of management at the date the
statements are made, and are subject to a variety of risks and
uncertainties and other factors that could cause actual events or
results to differ materially from those projected in the
forward-looking statements. The Company is under no obligation, and
expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable law.
The TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
SOURCE Aurora Cannabis Inc.